Ovoca Bio Plc

Board/Management Information • Dec 31, 2025

National Storage Mechanism | Additional information

RNS Number : 2044N

Ovoca Bio PLC

31 December 2025

Ovoca Bio PLC

31 December 2025

Ovoca Bio plc

("Ovoca" or the "Company")

Notice of AGM

Dublin, Ireland, December 31, 2025 - Ovoca Bio announces that its Notice of Annual General Meeting ("AGM"), containing details of the resolutions to be proposed at the AGM, has been published and is being posted to Shareholders. The Notice of AGM is also available on the Company's website at www.ovocabio.com

The Company's 2025 AGM will be held at The Mespil Hotel, 50-60 Mespil Road, Dublin 4, D04 E7N2, Ireland on January 27, 2026 at 10:30 a.m. Further details in relation to shareholder participation in the meeting is detailed in the Notice of AGM.

End

For further information:

Ovoca Bio plc

Tim McCutcheon (Chief Executive Officer)

Tel +353 1 661 9819

[email protected]

Beaumont Cornish Limited (Nominated Adviser)

James Biddle / Roland Cornish

Tel: +44 (0) 207 628 3396

CMC Markets UK Plc (Broker)

Thomas Smith / Thomas Curran

Tel: +44 (0) 20 3003 8632

Nominated Adviser Statement

Beaumont Cornish Limited ("Beaumont Cornish"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other person for providing the protections afforded to customers of Beaumont Cornish nor for advising them in relation to the transaction and arrangements described in the announcement or any matter referred to in it.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOABCBDDCBXDGUG